Enrollment is half complete in an ongoing clinical study at Massachusetts General Hospital (MGH) testing whether a PET imaging tracer can reliably measure myelin damage in people with multiple sclerosis (MS). The Phase 1 study (NCT04699747) is recruiting about 60 people — healthy adults and MS patients — who will receive the [18F]3F4AP tracer before undergoing […]

The post Enrollment in MS imaging study reaches halfway mark appeared first on Multiple Sclerosis News Today.

Source: multiplesclerosisnewstoday.com